S-EPMC5826089 - Risk of severe hematologic toxicities in cancer patients treated with PARP inhibitors: results of monotherapy and combination therapy trials. - OmicsDI

Unknown

Dataset Information

Risk of severe hematologic toxicities in cancer patients treated with PARP inhibitors: results of monotherapy and combination therapy trials.

ABSTRACT:

SUBMITTER: Alecu I

PROVIDER: S-EPMC5826089 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature